Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-076768
Filing Date
2011-08-12
Accepted
2011-08-12 15:18:34
Documents
16
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q m70918e10vq.htm 10-Q 834115
2 EX-2.1 m70918exv2w1.htm EX-2.1 792653
3 EX-2.2 m70918exv2w2.htm EX-2.2 228417
4 EX-2.3 m70918exv2w3.htm EX-2.3 235997
5 EX-2.4 m70918exv2w4.htm EX-2.4 45955
6 EX-2.5 m70918exv2w5.htm EX-2.5 9863
7 EX-31.1 m70918exv31w1.htm EX-31.1 8697
8 EX-31.2 m70918exv31w2.htm EX-31.2 8592
9 EX-32.1 m70918exv32w1.htm EX-32.1 3824
10 EX-32.2 m70918exv32w2.htm EX-32.2 3867
  Complete submission text file 0000950123-11-076768.txt   5216246

Data Files

Seq Description Document Type Size
11 EX-101 INSTANCE DOCUMENT aphi-20110630.xml EX-101.INS 682050
12 EX-101 SCHEMA DOCUMENT aphi-20110630.xsd EX-101.SCH 20526
13 EX-101 CALCULATION LINKBASE DOCUMENT aphi-20110630_cal.xml EX-101.CAL 53142
14 EX-101 LABELS LINKBASE DOCUMENT aphi-20110630_lab.xml EX-101.LAB 160985
15 EX-101 PRESENTATION LINKBASE DOCUMENT aphi-20110630_pre.xml EX-101.PRE 107862
16 EX-101 DEFINITION LINKBASE DOCUMENT aphi-20110630_def.xml EX-101.DEF 22552
Mailing Address 22 INVERNESS CENTER PARKWAY SUITE 310 BIRMINGHAM AL 35242
Business Address 22 INVERNESS CENTER PARKWAY SUITE 310 BIRMINGHAM AL 35242 205-991-8085
Aptalis Pharma Inc (Filer) CIK: 0001444570 (see all company filings)

EIN.: 743249870 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 333-153896 | Film No.: 111031069
SIC: 2834 Pharmaceutical Preparations